BeStock  

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #452Infectious DiseaseCannabis & Hemp
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership79.4%-1.37 pts vs. prior quarter
Institutions holding782-1 vs. prior quarter
Insider trades (recent)23 buys / 24 sellsNet selling
Short interest2.38% of floatDays to cover 5.3 · as of 30 Oct 2026
Short-sale volume share14.3%5-day average of daily volume

Short-sale volume as % of daily volume

5%10%15%20%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$70.16M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$42.3MSuper−$27.8MBig−$39.4MMid−$42.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.7% of shares outstanding.

Largest holders

  • Harel Insurance Investments & Financial Services Ltd8.92%
  • Norges Bank Investment Management6.01%
  • BlackRock5.44%
  • Phoenix Investments & Finances Ltd4.85%
  • Menora Mivtachim Provident Funds4.48%
  • Vanguard Capital Management, LLC3.68%
  • WCM Investment Management3.62%
  • Clal Financial Management Ltd3.61%

By investor type

  • Mutual Fund52.46%
  • Public Company11.21%
  • Sovereign Wealth Fund6.06%
  • Hedge Fund4.47%
  • Private Company1.66%
  • Government Pension Fund1.62%
  • Family Office/Trust1.57%
  • Individual/Insider0.41%

Reported short interest has fallen from 3.06% to 2.38% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Menora Mivtachim Provident Funds Mutual Fund 2026/Q4 +12,421,436 4.5%
Amundi Asset Management Mutual Fund 2026/Q4 +1,650,490 0.3%
Harel Insurance Investments & Financial Services Ltd Public Company 2026/Q4 +55,283,251 8.9%
BlackRock Mutual Fund 2026/Q3 +27,909,722 8.4%
Hardman Johnston Global Advisors LLC Mutual Fund 2026/Q4 +5,360,604 0.5%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q4 +4,744,191 0.5%
Susquehanna International Group, LLP Private Company 2026/Q4 +3,219,710 0.3%
More Investment House Ltd. Mutual Fund 2026/Q4 +3,211,551 0.6%
Qube Research & Technologies Ltd Mutual Fund 2026/Q4 +2,976,366 0.3%
Marshall Wace LLP Hedge Fund 2026/Q4 +2,782,756 0.2%
Capital Research Mutual Fund 2026/Q4 +2,632,531 1.5%
Glenview Capital Management, LLC Hedge Fund 2026/Q4 +2,485,786 0.6%
State Street Global Advisors Mutual Fund 2026/Q3 +2,321,196 1.8%
Legal & General Investment Management Mutual Fund 2026/Q4 +2,060,443 0.5%
WCM Investment Management Mutual Fund 2026/Q3 +1,935,586 3.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Mark Sabag Executive Vice President of International Markets Commercial Derivative Exercise and Sale -44,710 $44.14 80,760
10 Nov 2026 Richard Daniell Executive Vice President of European Commercial Intent to Sell (Form 144) -20,003 $42.80 –
10 Nov 2026 Richard Daniell Executive Vice President of European Commercial Derivative Exercise and Sale -45,003 $42.91 55,755
9 Nov 2026 David Brailer Independent Director Other Derivative Acquisition +3,326 – 3,326
9 Nov 2026 Richard Francis Chief Executive Officer Automatic Disposition -250,000 $42.24 927,529
9 Nov 2026 Dov Bergwerk Senior VP & Company Secretary Other Derivative Acquisition +9,433 – 9,433
8 Nov 2026 Richard Daniell Executive Vice President of European Commercial Intent to Sell (Form 144) -25,000 $42.91 –
8 Nov 2026 Amir Weiss Chief Accounting Officer Open Market Disposition -9,534 $43.03 3,537
8 Nov 2026 Amir Weiss Chief Accounting Officer Derivative Exercise and Sale -7,755 $43.15 3,537
4 Nov 2026 Mark Sabag Executive Vice President of International Markets Commercial Derivative Exercise and Sale -46,000 $41.93 80,760
3 Nov 2026 Dov Bergwerk Senior VP & Company Secretary Derivative Exercise and Sale -26,260 $41.72 11,943
28 Sep 2026 Dov Bergwerk Senior VP & Company Secretary Initial Statement of Beneficial +0 – 26,260
17 Sep 2026 Bridger Management LLC Intent to Sell (Form 144) -367,600 $39.19 –
17 Sep 2026 Brian Savage Interim Chief Legal Officer Open Market Disposition -2,839 $39.15 8,500
17 Sep 2026 Brian Savage Interim Chief Legal Officer Derivative Exercise and Sale -4,503 $38.69 8,500
20 Aug 2026 Ronit Satchi-Fainaro Independent Director Private Disposition -415 $37.25 111,986
20 Aug 2026 Amir Weiss Chief Accounting Officer Private Disposition -6,945 $37.61 13,071
20 Aug 2026 Amir Weiss Chief Accounting Officer Derivative Exercise and Sale -2,500 $37.63 13,071
16 Aug 2026 Evan Lippman Officer Automatic Disposition -18,600 $36.57 25,591
4 Aug 2026 Tal Zaks Independent Director Private Disposition -17 $34.87 73,247

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 27,739,194 2.4% 5.3
15 Oct 2026 28,070,513 2.4% 3.9
30 Sep 2026 29,848,805 2.6% 5.4
15 Sep 2026 31,478,314 2.7% 27.4
31 Aug 2026 37,614,253 3.2% 7.7
14 Aug 2026 35,670,864 3.1% 6.6

Discussion

No comments yet — be the first to weigh in on TEVA.

Sign in to join the discussion.

Scroll to Top